10 September, 2024

Post-COVID Syndrome: Government-Funded Drug Study Gets Underway

An innovative study for the treatment of post-COVID syndrome (PCS) is starting under the direction of Frankfurt University Hospital’s Department of Infectious Diseases. The research project, funded by the German Federal Ministry of Education and Research (BMBF), will investigate new ways of alleviating the long-term effects of COVID-19, including fatigue and cognitive impairment.

10 September, 2024

Researchers Propose Multimodal Approach To Tackle Post-Acute Infectious Syndromes, Including Long COVID

In a world still grappling with the aftermath of the COVID-19 pandemic, a team of international researchers has proposed a novel approach to treating the persistent symptoms that plague many survivors of viral infections. The study, published in Brain Medicine, outlines a multimodal treatment strategy that could offer hope to millions suffering from post-acute infectious syndromes (PAIS), including the condition commonly known as long COVID. Dr. Charlotte Steenblock, lead author of the study from the University Hospital Carl Gustav Carus in Dresden, Germany, explains, "We've learned that post-viral syndromes are incredibly complex, with no single cause or cure. Our research suggests that by combining different treatment modalities, we might be able to reset the body's systems and provide relief to those suffering from these debilitating conditions."

09 September, 2024

Living With Long COVID: What It’s Like To Be Diagnosed With The Debilitating Disease

Even mild cases of COVID-19 are linked to potential long-term repercussions — some of them deadly serious.